{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["37(4)"],"submitter":["Orscelik A"],"pubmed_abstract":["<h4>Background</h4>The comparison of mechanical thrombectomy (MT) outcomes between patients with the hyperdense middle cerebral artery sign (HMCAS) and non-HMCAS is important to evaluate the impact of this radiological finding on treatment efficacy. This meta-analysis aimed to assess the association between HMCAS and clinical outcomes in patients undergoing thrombectomy, comparing the outcomes over non-HMCAS.<h4>Methods</h4>A systematic literature search was conducted in PubMed, Ovid Embase, Google Scholar, and Cochrane Library to identify studies on MT outcomes for M1 occlusions of HMCAS over non-HMCAS. Inclusion criteria encompassed modified Rankin Scale (mRS) score, mortality, symptomatic intracranial hemorrhage (sICH), and successful recanalization. Using R software version 4.1.2, we calculated pooled odds ratios (ORs) and their corresponding 95% confidence intervals (CI).<h4>Results</h4>The meta-analysis was performed for 5 studies with 724 patients. There was no association found between presence of HMCAS and achieving mRS 0-2 (OR = 0.65, 95% CI: 0.29-1.47; <i>p</i> = .544). Mortality analysis also showed no significant association with presence of HMCAS (OR = 0.78, 95% CI: 0.37-1.65; <i>p</i> = .520). No significant difference in sICH risk (OR = 1.54, 95% CI: 0.24-9.66; <i>p</i> = .646) was found between groups. Recanalization analysis showed a non-significant positive association (OR = 1.23, 95% CI: 0.67-2.28; <i>p</i> = .501). Heterogeneity was observed in all analyses.<h4>Conclusion</h4>Our findings showed that there is no statistically significant difference in mRS scores, mortality, sICH, and recanalization success rates between the HMCAS and non-HMCAS groups."],"journal":["The neuroradiology journal"],"pagination":["454-461"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11366193"],"repository":["biostudies-literature"],"pubmed_title":["Outcomes of mechanical thrombectomy in M1 occlusion patients with or without hyperdense middle cerebral artery sign: A systematic review and meta-analysis."],"pmcid":["PMC11366193"],"pubmed_authors":["Zandpazandi S","Arul S","Ghozy S","Senol YC","Pakkam M","Brinjikji W","Bilgin GB","Musmar B","Kallmes DF","Orscelik A","Bilgin C","Kobeissi H"],"additional_accession":[]},"is_claimable":false,"name":"Outcomes of mechanical thrombectomy in M1 occlusion patients with or without hyperdense middle cerebral artery sign: A systematic review and meta-analysis.","description":"<h4>Background</h4>The comparison of mechanical thrombectomy (MT) outcomes between patients with the hyperdense middle cerebral artery sign (HMCAS) and non-HMCAS is important to evaluate the impact of this radiological finding on treatment efficacy. This meta-analysis aimed to assess the association between HMCAS and clinical outcomes in patients undergoing thrombectomy, comparing the outcomes over non-HMCAS.<h4>Methods</h4>A systematic literature search was conducted in PubMed, Ovid Embase, Google Scholar, and Cochrane Library to identify studies on MT outcomes for M1 occlusions of HMCAS over non-HMCAS. Inclusion criteria encompassed modified Rankin Scale (mRS) score, mortality, symptomatic intracranial hemorrhage (sICH), and successful recanalization. Using R software version 4.1.2, we calculated pooled odds ratios (ORs) and their corresponding 95% confidence intervals (CI).<h4>Results</h4>The meta-analysis was performed for 5 studies with 724 patients. There was no association found between presence of HMCAS and achieving mRS 0-2 (OR = 0.65, 95% CI: 0.29-1.47; <i>p</i> = .544). Mortality analysis also showed no significant association with presence of HMCAS (OR = 0.78, 95% CI: 0.37-1.65; <i>p</i> = .520). No significant difference in sICH risk (OR = 1.54, 95% CI: 0.24-9.66; <i>p</i> = .646) was found between groups. Recanalization analysis showed a non-significant positive association (OR = 1.23, 95% CI: 0.67-2.28; <i>p</i> = .501). Heterogeneity was observed in all analyses.<h4>Conclusion</h4>Our findings showed that there is no statistically significant difference in mRS scores, mortality, sICH, and recanalization success rates between the HMCAS and non-HMCAS groups.","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Aug","modification":"2026-06-03T07:03:27.584Z","creation":"2025-08-18T09:54:13.717Z"},"accession":"S-EPMC11366193","cross_references":{"pubmed":["38146685"],"doi":["10.1177/19714009231224446"]}}